Prognostic Value of Delta LUS Score of Patients Hospitalized for Acute Heart Failure (Deltalus)

May 13, 2023 updated by: Pr. Semir Nouira, University of Monastir

Prognostic Value of Delta LUS Score of Patients Hospitalized for Acute Heart Failure Within 30 Days of Discharge

prognostic value of delta LUS score of patients hospitalized for acute heart failure within 30 days of discharge.

Study Overview

Status

Recruiting

Conditions

Detailed Description

The aim of our study is to evaluate the contribution of the variation of the LUS score performed at the time of admission (LUS1) and at discharge (LUS2) in predicting the clinical course of patients admitted for acute cardiac decompensation 30 days after discharge.

Delta LUS score=((LUS2-LUS1) *100)/LUS1

Study Type

Observational

Enrollment (Anticipated)

500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • Tunisia
      • Monastir, Tunisia, 5000
        • Recruiting
        • Emergency Departement
        • Contact:
        • Contact:
        • Principal Investigator:
          • semir nouira, professor
    • Monastur
      • Monastir, Monastur, Tunisia, 5000
        • Recruiting
        • Semir Nouira
        • Contact:
        • Contact:
          • Phone Number: +21673106046

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

This is a prospective observational study that will be conducted in the emergency department of CHU Fattouma Bourguiba Monastir over a period from March 2023 to December 2023.

Will be included in this study patients aged over 18 years, hospitalized in the emergency department for dyspnea having as etiology an acute heart failure and in whom will be performed two pulmonary ultrasound examinations (at entry and exit). These patients will be contacted after one month of their discharge from the hospital

Description

Inclusion Criteria:

  • Patients aged over 18 years,
  • Patients hospitalized in the emergency department for dyspnea having as etiology an acute heart failure and in whom will be performed two pulmonary ultrasound examinations (at entry and exit).

Exclusion Criteria:

  • Age less than 18 years
  • Dyspnea of non-cardiac etiology (cause: pulmonary, traumatic, toxic...)
  • Altered state of consciousness (Glasgow score<14)
  • Hemodynamic instability: presence of peripheral signs of shock, use of vasoactive drugs
  • Mechanical ventilation from the outset
  • Cardiorespiratory arrest
  • Inability to give consent to the study
  • Missing one of two ultrasound examinations
  • Unable to make telephone contact after one month.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Delta lus
Time Frame: 30 days
The primary outcome evaluate the contribution of the variation of the LUS score performed at the time of admission (LUS1) and at discharge (LUS2) in predicting the clinical course of patients admitted for acute cardiac
30 days
Readmission
Time Frame: 30 days
Readmission
30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Monastir

Investigators

  • Principal Investigator: Nouira Semir, Pr, University of Monastir

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 30, 2023

Primary Completion (Anticipated)

December 30, 2023

Study Completion (Anticipated)

December 30, 2023

Study Registration Dates

First Submitted

March 17, 2023

First Submitted That Met QC Criteria

May 13, 2023

First Posted (Actual)

May 23, 2023

Study Record Updates

Last Update Posted (Actual)

May 23, 2023

Last Update Submitted That Met QC Criteria

May 13, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Delta- LUS

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Emergencies

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe